Sign in

CIK 0001540159

  • Non-accelerated filer
  • Smaller reporting company

Edesa Biotech, Inc.

Sign in to watch
Ticker
EDSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
British Columbia, Canada
Entity type
Operating
Phone
+1 905-475-1234
Business address
C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
Former names
Stellar Biotechnologies, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-10-12 MORSE DANIEL E. Former Director Sale −7,047 $1.31 $9K 20,741
2018-03-29 MORSE DANIEL E. Director Sale −4,366 $0.81 $4K 0
2018-03-12 MORSE DANIEL E. Director Sale −3,500 $0.80 $3K 4,366
2018-03-12 MORSE DANIEL E. Director Grant or award · Share Option (Right to Buy) +2,500 2,500
2018-03-09 MORSE DANIEL E. Director Sale −7,000 $0.81 $6K 7,866
2018-02-28 MORSE DANIEL E. Director Sale −7,000 $0.79 $6K 14,866
2018-02-26 MORSE DANIEL E. Director Sale −7,000 $0.79 $6K 21,866
2018-02-22 MORSE DANIEL E. Director Sale −7,800 $0.78 $6K 28,866
2017-06-26 MORSE DANIEL E. Director Grant or award +134,680 231,189
2017-03-23 MORSE DANIEL E. Director Grant or award · Share Option (Right to Buy) +2,500 2,500
2016-12-20 MORSE DANIEL E. Director Grant or award · Share Option (Right to Buy) +2,500 2,500
2015-06-10 MORSE DANIEL E. Director Grant or award · Stock Option (Right to Buy) +25,000 25,000

Page 1 of 1 · 12 trades